or Try an Advanced Search...

    Technical Analysis for NRXP - NeuroRx, Inc.

    Grade Last Price % Change Price Change
    F 2.82 0.36% 0.01
    NRXP closed up 0.36 percent on Wednesday, May 8, 2024, on 82 percent of normal volume.
    Earnings due: May 14
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Up
    Historical NRXP trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.36%
    Calm After Storm Range Contraction 0.36%
    Inside Day Range Contraction 0.36%
    Wide Bands Range Expansion 0.36%
    Oversold Stochastic Weakness 0.36%
    20 DMA Resistance Bearish -7.84%
    200 DMA Resistance Bearish -7.84%
    New Uptrend Bullish -7.84%
    Older End-of-Day Signals for NRXP ...

       Recent Intraday Alerts

    Alert Time
    Up 5% about 12 hours ago
    60 Minute Opening Range Breakout about 12 hours ago
    Down 3% about 15 hours ago
    Non-ADX 1,2,3,4 Bearish Retracement Entry about 15 hours ago
    Fell Below Previous Day's Low about 15 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    NRXP Chart by TradingView
    Basic chart:

    Profile

    NeuroRx, Inc. operates as a clinical stage-small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders. Its drug candidate includes Cyclurad, an oral therapeutic for the treatment of acute/elevated suicidal ideation/crisis in bipolar depression. The company was incorporated in 2015 and is headquartered in Wilmington, Delaware.
    Classification
    Sector: Industrials
    Industry: Conglomerates
    Keywords: Life Sciences Health Sciences Health Care Central Nervous System Disorders Antidepressants Bipolar Disorder Treatment Of Central Nervous System Disorders Atypical Antipsychotics Bipolar Depression

    Is NRXP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 8 NRx Pharmaceuticals Eyes First Commercial Revenue in 2024, Announces Breakthroughs in Bi-Annual Milestone Update
    May 8 NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024
    May 7 NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Report First Quarter 2024 Financial Results on May 14, 2024
    May 6 NRx Pharmaceuticals climbs on positive results from its bipolar depression treatment trial
    May 6 NRx Pharmaceuticals (Nasdaq:NRXP) Announces Final Clinical Trial Results: Superior Safety Combined with Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar Depression
    Apr 30 Why Is NRx Pharmaceuticals Stock Falling After Data From Suicidal Bipolar Depression Study
    Apr 30 NRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar Depression
    Apr 18 NRx Pharmaceuticals receives Nasdaq notice on demonstrating compliance with bid price requirement
    Apr 18 NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement
    Apr 18 NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock
    See more NRXP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 12.0
    52 Week Low 1.9
    Average Volume 488,181
    200-Day Moving Average 3.72
    50-Day Moving Average 4.44
    20-Day Moving Average 3.35
    10-Day Moving Average 2.78
    Average True Range 0.60
    RSI (14) 39.02
    ADX 25.15
    +DI 28.06
    -DI 27.53
    Chandelier Exit (Long, 3 ATRs) 4.19
    Chandelier Exit (Short, 3 ATRs) 3.71
    Upper Bollinger Bands 5.26
    Lower Bollinger Band 1.45
    Percent B (%b) 0.36
    BandWidth 113.74
    MACD Line -0.56
    MACD Signal Line -0.56
    MACD Histogram -0.0037
    Fundamentals Value
    Market Cap 240.17 Million
    Num Shares 85.2 Million
    EPS -0.50
    Price-to-Earnings (P/E) Ratio -5.64
    Price-to-Sales 0.00
    Price-to-Book 6.95
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.29
    Resistance 3 (R3) 3.30 3.14 3.22
    Resistance 2 (R2) 3.14 3.02 3.14 3.19
    Resistance 1 (R1) 2.98 2.95 2.91 2.98 3.16
    Pivot Point 2.83 2.83 2.79 2.83 2.83
    Support 1 (S1) 2.67 2.71 2.59 2.66 2.48
    Support 2 (S2) 2.51 2.63 2.51 2.45
    Support 3 (S3) 2.35 2.51 2.43
    Support 4 (S4) 2.35